Book Chapter10.1016/B978-1-4160-0292-5.00029-2
28 – Stereotactic Radiosurgery for Pituitary Adenomas
Jason P. Sheehan,Mary Lee Vance,Jay Jagannathan,Ladislau Steiner +3 more
- 01 Jan 2010
pp 290-299
About: The article was published on 01 Jan 2010. The article focuses on the topics: Radiosurgery.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Radiosurgery for growth hormone—producing pituitary adenomas
TL;DR: Growth hormone levels declined with improvement in acromegaly in all cases in the first 6 months after GKS, and normalization of the hormone levels was achieved in 23 of 58 patients who had been followed for 12 months and in 96% of cases for more than 24 months or more than 36 months.
Cushing's syndrome: historical aspects.
TL;DR: A brief overview of the most important steps leading to the present knowledge of hypercorticism is given.
Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma
TL;DR: The combination of transsphenoidal microsurgery and adjuvant GKS is the optimal therapy for patients with GH-secreting adenoma, based on recently accepted biochemical cure criteria.
A comparison between magnetic resonance imaging and computed tomography for stereotactic coordinate determination.
Douglas Kondziolka,Peter K. Dempsey,Lunsford Ld,John R. W. Kestle,E.J. Dolan,Emanuel Kanal,Ronald R. Tasker +6 more
TL;DR: It is concluded that MRI-guided stereotactic localization can be used with confidence for most diagnostic, functional, and therapeutic stereootactic procedures.
Results of transsphenoidal surgery for Cushing's disease in patients with no histologically confirmed tumor.
Jonas M. Sheehan,M. Beatriz S. Lopes,Jason P. Sheehan,Dilantha B. Ellegala,Kristopher M. Webb,Edward R. Laws +5 more
TL;DR: Patients with no histological confirmation of tumor after transsphenoidal surgery for Cushing's disease are likely to have a good outcome, and the results do not differ significantly from reported cure rates in patients with confirmed adenomas.